来自MSN2 个月
EyePoint initiated at buy by Citi on wAMD drug potential
C iti has initiated coverage of EyePoint Pharmaceuticals (NASDAQ:EYPT) with a buy rating, stating it sees the company's drug Duravyu as well-positioned to compete in the wet age-related macular ...
Zawya4 天
NBK highlights key security guidelines for safe use of “WAMD”
As part of the campaign, NBK is raising awareness among customers about fraudulent schemes targeting Instant Payment Service (WAMD). The bank underscores the importance of recognizing these tactics ...
Ocular Therapeutix initiated with a Buy at Needham
Needham analyst Serge Belanger initiated coverage of Ocular Therapeutix (OCUL) with a Buy rating and $15 price target citing Axpaxli’s ...